COMBI-AD: Dabrafenib plus trametinib in advanced melanoma
11 Sep 2017
COMBI-AD: Dabrafenib plus trametinib in advanced melanoma
Checkmate 238: Adjuvant checkpoint therapy after melanoma resection
The role of tumour marker testing in early diagnosis
The METRIC trial of trametinib, five years on
New strategies in melanoma care
RANGE trial of ramucirumab for urothelial cancer
Adaptive TONIC trial of nivolumab combinations for breast cancer
Panitumumab triplet therapy in colorectal cancer
Long term efficacy of denosumab for giant cell bone tumours
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer
PACIFIC trial of durvalumab for stage III NSCLC